8 results about "Intravenous use" patented technology

The article to which this design pertains is an arm cover. This article (arm cover) is used to prevent hospitalized patients from removing their intravenous drips.

To provide a program that outputs symptom information regarding signs of self-removal of intravenous drip. [Solution] The program acquires time-series data regarding the movement of a second hand, different from the first hand being punctured, and outputs symptom information by inputting the acquired time-series data into a learning model that outputs symptom information regarding signs of self-removal of an IV drip when time-series data is input. Preferably, the program acquires video data of the puncture site and the movement of the second hand captured by a camera, and inputs the video data into the learning model to output the symptom information.

The utility model relates to an equipment belt structure for an assembled ward. The equipment belt structure comprises a mounting unit, a main body unit, a locking unit, a hook unit and an adjusting unit, the connecting structure has the advantages that after the mounting unit is connected with the wall body, the mounting unit is connected with the main body unit in a clamping mode, traditional punching bolt fixing is replaced, damage to a prefabricated wall body structure is avoided, the integrity of the wall body and the advantages of a fabricated building are reserved, meanwhile, the mounting process is simplified, and the construction efficiency is improved; movement of the main body unit can be limited by the locking unit, loosening and displacement of the equipment belt caused by external force collision are avoided, and use safety is guaranteed. The hook unit is matched with the adjusting unit, so that the limitation that the hanging position of an infusion bottle is fixed is solved. The adjusting unit can flexibly adjust the transverse position of the hook unit according to the actual requirements of patients and the position change of the sickbed, the infusion requirements of different patients are met, and operation of medical staff is facilitated.

The application discloses a kind of oral sustained-release composition of edaravone, preparation method and application.The application provides a kind of pharmaceutical composition, it includes tablet core and coating;The tablet core includes drug-containing layer tablet core and / or boost layer tablet core;The drug-containing layer tablet core includes edaravone pharmaceutical active ingredient and carrier;The carrier is one or more in polymer carrier, osmotic pressure regulator, swelling agent, thickening agent and lubricant;The boost layer tablet core includes one or more in osmotic pressure regulator, swelling agent, colorant and lubricant.The pharmaceutical composition of the application maintains 24 hours sustained-release, oral convenient, blood drug concentration is stable, avoids the method of 2 times intravenous drip in a day, improves patient compliance.In addition, the pharmaceutical composition, prescription and preparation process are simple, easy to industrial production.

The invention discloses an application of a pharmaceutical composition in preparation of a medicine for promoting blood circulation to remove blood stasis, and relates to the technical field of traditional Chinese medicine compound preparations, the pharmaceutical composition comprises the following seven components: a Xuesaitong injection, a ginkgo dipyridamole injection, a salvia miltiorrhiza injection, an astragalus membranaceus injection, a blood pricking and bloodletting device, a Xiaoyao pill oral preparation and a pulse-activating decoction oral liquid; the application method comprises the following steps: sequentially carrying out intravenous drip injection of the Xuesaitong injection, the Ginkgo damole injection and intravenous drip of the Salvia miltiorrhiza injection; then a blood pricking and bloodletting device is used for cooperating operation; and then, carrying out intravenous drip of the astragalus membranaceus injection for administration. After injection, the Xiaoyao pills and the pulse-activating decoction are orally taken; through intravenous injection, blood pricking therapy and oral consolidated drug action paths, a new application way of the pharmaceutical composition in the blood circulation promoting and blood stasis removing drugs is provided, clear sequential use of the blood circulation promoting and blood stasis removing pharmaceutical composition is achieved, the purposes of rapid blood circulation promoting and blood stasis removing and long-acting physique conditioning of the pharmaceutical composition are achieved, and the pharmaceutical composition is safe and efficient.

The article to which this design pertains is an arm cover. This article (arm cover) is used to prevent hospitalized patients from removing their intravenous drips.

The present application discloses a composition for treating painful disc injury syndrome (PDDS), disc bulging, disc herniation, and disc herniation, as well as a delivery method and recommended treatment regimen for delivering an effective dose of the composition to a patient. The composition has the characteristics of inflammation resistance, oxidation resistance, vasodilation and spasmolysis. The composition is administered by intravenous drip over a specific period of time to relieve pain.

The invention relates to the technical field of intravenous therapy data tracking, in particular to an intravenous therapy information data tracking method, system and equipment, and the method comprises the steps: determining an information effective factor of each moment in each time period of each patient; according to the difference between the intravenous drip speed at each moment in each time period and the intravenous drip speed in the neighborhood of each time period, in combination with the information effective factor, determining an intravenous therapy characteristic factor of each patient at each moment in each time period; according to the difference between the feature vectors of all data tracking moments of each patient in any time period and the feature vectors of all data tracking moments of other patients in any time period in the same type of disease group, vein treatment data of the patients are tracked. According to the method, the related data in the vein treatment process is comprehensively analyzed, the vein treatment similarity between the patients in the same type of disease group is determined, the accuracy of effective information extraction is improved, and the credibility of the vein treatment related data is enhanced.